202 related articles for article (PubMed ID: 18451232)
1. Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
Brennan DJ; Rexhepaj E; O'Brien SL; McSherry E; O'Connor DP; Fagan A; Culhane AC; Higgins DG; Jirstrom K; Millikan RC; Landberg G; Duffy MJ; Hewitt SM; Gallagher WM
Clin Cancer Res; 2008 May; 14(9):2681-9. PubMed ID: 18451232
[TBL] [Abstract][Full Text] [Related]
2. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
[TBL] [Abstract][Full Text] [Related]
3. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K
J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
[TBL] [Abstract][Full Text] [Related]
4. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.
Ko YH; Roh SY; Won HS; Jeon EK; Hong SH; Lee MA; Kang JH; Hong YS; Kim MS; Jung CK
Head Neck Oncol; 2010 Oct; 2():30. PubMed ID: 21034499
[TBL] [Abstract][Full Text] [Related]
6. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
[TBL] [Abstract][Full Text] [Related]
7. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer.
Preuss SF; Weinell A; Molitor M; Stenner M; Semrau R; Drebber U; Weissenborn SJ; Speel EJ; Wittekindt C; Guntinas-Lichius O; Hoffmann TK; Eslick GD; Klussmann JP
Br J Cancer; 2008 Feb; 98(3):627-32. PubMed ID: 18212752
[TBL] [Abstract][Full Text] [Related]
8. Expression of survivin and clinical correlation in patients with breast cancer.
Sohn DM; Kim SY; Baek MJ; Lim CW; Lee MH; Cho MS; Kim TY
Biomed Pharmacother; 2006 Jul; 60(6):289-92. PubMed ID: 16876381
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of survivin in pancreatic endocrine tumors.
Ekeblad S; Lejonklou MH; Stålberg P; Skogseid B
World J Surg; 2012 Jun; 36(6):1411-8. PubMed ID: 22089920
[TBL] [Abstract][Full Text] [Related]
10. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.
Hinnis AR; Luckett JC; Walker RA
Br J Cancer; 2007 Feb; 96(4):639-45. PubMed ID: 17285125
[TBL] [Abstract][Full Text] [Related]
11. [Nuclear and cytoplasmic expressions of survivin in glioma and their prognostic value].
Pan Y; Hu WH; Xie D; Wu QL; Liu YH; Xiang J; Wu HX
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):325-9. PubMed ID: 17456361
[TBL] [Abstract][Full Text] [Related]
12. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.
Nassar A; Lawson D; Cotsonis G; Cohen C
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):113-20. PubMed ID: 18227733
[TBL] [Abstract][Full Text] [Related]
13. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.
Yin W; Chen N; Zhang Y; Zeng H; Chen X; He Y; Wang X; Zhou Q
Mod Pathol; 2006 Nov; 19(11):1487-97. PubMed ID: 16892011
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
[TBL] [Abstract][Full Text] [Related]
15. Expression of survivin does not appear to influence breast cancer recurrence risk.
Collin LJ; Cronin-Fenton DP; Ahern TP; Christensen KB; Damkier P; Hamilton-Dutoit S; Kjaersgaard A; Lauridsen KL; Yacoub R; Christiansen P; Sørensen HT; Lash TL
Acta Oncol; 2019 Feb; 58(2):154-161. PubMed ID: 30351173
[TBL] [Abstract][Full Text] [Related]
16. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
[TBL] [Abstract][Full Text] [Related]
17. A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.
Frolova N; Edmonds MD; Bodenstine TM; Seitz R; Johnson MR; Feng R; Welch DR; Frost AR
Tumour Biol; 2009; 30(3):148-59. PubMed ID: 19609101
[TBL] [Abstract][Full Text] [Related]
18. Survivin is an independent prognostic marker for risk stratification of breast cancer patients.
Span PN; Sweep FC; Wiegerinck ET; Tjan-Heijnen VC; Manders P; Beex LV; de Kok JB
Clin Chem; 2004 Nov; 50(11):1986-93. PubMed ID: 15364883
[TBL] [Abstract][Full Text] [Related]
19. Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.
Tonini G; Vincenzi B; Santini D; Scarpa S; Vasaturo T; Malacrino C; Coppola R; Magistrelli P; Borzomati D; Baldi A; Antinori A; Caricato M; Nuzzo G; Picciocchi A
Br J Cancer; 2005 Jun; 92(12):2225-32. PubMed ID: 15928668
[TBL] [Abstract][Full Text] [Related]
20. Survivin expression and impact on head and neck cancer outcomes.
Khan SA; Burke M; Zhu F; Yang DH; Dubyk C; Mehra R; Lango MJ; Ridge JA; Sher DJ; Burtness B
Oral Oncol; 2021 Jan; 112():105049. PubMed ID: 33221541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]